Poor Supplier Control Causing Recalls, FDA Says; Contract Is Key To Success
This article was originally published in The Silver Sheet
Executive SummarySUPPLIER CONTROL PROBLEMS ARE ON THE RISE and may be contributing to an increase in medical device recalls, says FDA Quality Systems Expert Kim Trautman. "When the recalls come in and [firms are] identifying some of the causes for the recall, it seems to be more prevalent within the past five or so years that they are supplier issues," she notes. To combat the trend, FDA has begun emphasizing to industry the importance of complying with purchasing controls, as well as ensuring that supplier contracts adequately outline product and service requirements. "Sometimes the contracts and the expectations between the finished device manufacturer and the supplier are just too loose," Trautman says. Meanwhile, the agency admits it is having a tough time keeping up with "virtual manufacturing" and "internal supplying" arrangements...
You may also be interested in...
ConMed's CFO Todd Garner told delegates at the Jefferies Healthcare conference that the company's orthopedic franchise is focused on its pipeline and meeting customer's needs. See what the CFO said about it here.
Formal dispute resolution was key element in four-month turnaround from rejection by US FDA to approval for golodirsen, the second Sarepta DMD drug to clear the agency after appearing to have minimal prospects.
Correvio’s attempt to move vernakalant from 'clinical hold' to 'FDA approved' was a huge long shot. But the advisory committee vote – and looming FDA rejection – are another indication that real-world data is not a panacea.